Showing results (81-90 of 618) with videos related to
Sort By:
Pageof 62
Cancer|January 21, 2000
UFT plus cisplatin combination chemotherapy in the treatment of patients with advanced nonsmall cell lung carcinoma: a multiinstitutional phase II trial. For the Japan UFT Lung Cancer Study GroupY Ichinose, K Yosimori, S Yoneda, et al.Cancer Chemotherapy and Pharmacology|July 8, 1998
Phase I study of E7010K Yamamoto, K Noda, A Yoshimura, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Phase II trial of docetaxel in previously untreated advanced non-small-cell lung cancer: a Japanese cooperative studyH Kunitoh, K Watanabe, T Onoshi, et al.Oncogene|April 21, 2001
A variant of nuclear localization signal of bipartite-type is required for the nuclear translocation of hypoxia inducible factors (1alpha, 2alpha and 3alpha)J C Luo, M ShibuyaNihon Geka Gakkai Zasshi|May 1, 1996
[Interphase cytogenetics of the breast tumors with fluorescence in situ hybridization (FISH) on cytologic preparation--its practice and clinical applications]M Shibuya, R Y OsamuraJournal of Cancer Research and Clinical Oncology|January 1, 1982
Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumorsN Saijo, E Shimizu, N Irimajiri, et al.Journal of Cardiology|December 1, 1988
[Effects of bathing on cardiac function in patients with myocardial infarction: hemodynamic and Doppler echocardiographic studies]M Ozawa, M Hasegawa, A Matsuzaki, et al.Acta Pathologica Japonica|October 1, 1991
Clinicopathologic and immunohistochemical characteristics of goblet cell type adenocarcinoma of the lungA Gemma, M Noguchi, S Hirohashi, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1992
[A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)]K Furuse, M Fukuoka, H Asamoto, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 1, 1990
[Phase I study of MST-16]H Furue, H Niitani, I Nakao, et al.Pageof 62